The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Bnse71F
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» BE's pediatric pneumonia jab gets CDSCO expert panel approval
0 comments:
Post a Comment